SM
VRPX
Sabby Management’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-292,790
| Closed | -$234K | – | 82 |
|
|
2023
Q3 | $234K | Sell |
292,790
-107,210
| -27% | -$85.8K | 0.17% | 26 |
|
|
2023
Q2 | $432K | Sell |
400,000
-301,455
| -43% | -$326K | 0.35% | 28 |
|
|
2023
Q1 | $551K | Sell |
701,455
-286,710
| -29% | -$225K | 0.48% | 17 |
|
|
2022
Q4 | $615K | Sell |
988,165
-66,235
| -6% | -$41.2K | 0.54% | 17 |
|
|
2022
Q3 | $1.26M | Sell |
1,054,400
-4,983
| -0.5% | -$5.93K | 1.58% | 10 |
|
|
2022
Q2 | $1.78M | Buy |
1,059,383
+54,227
| +5% | +$91.1K | 1.21% | 6 |
|
|
2022
Q1 | $18.3M | Buy |
1,005,156
+128,322
| +15% | +$2.34M | 2.74% | 2 |
|
|
2021
Q4 | $3.01M | Sell |
876,834
-116,166
| -12% | -$399K | 0.44% | 18 |
|
|
2021
Q3 | $4.77M | Buy |
993,000
+838,263
| +542% | +$4.02M | 0.64% | 7 |
|
|
2021
Q2 | $704K | Sell |
154,737
-45,263
| -23% | -$206K | 0.1% | 55 |
|
|
2021
Q1 | $942K | Buy |
+200,000
| New | +$942K | 0.18% | 42 |
|